Diagnostic und Therapeutic Value of Cell-free Circulating DNA as a Non-invasive Biomarker in Patients with Prostate Cancer

Author(s): Stefan Latz, Stefan C. Muller, Jorg Ellinger

Journal Name: Current Cancer Therapy Reviews

Volume 9 , Issue 4 , 2013

Become EABM
Become Reviewer
Call for Editor


The presence of small amounts of circulating DNA in plasma was demonstrated 60 years ago. Since then, cellfree DNA has been tested for quantity, fragmentation pattern and tumor-specific sequences in patients with various malignancies. The introduction of improved detection methods showed that all these alterations are regularly detectable in many cancer patients and the investigation of cell-free DNA may provide useful diagnostic and prognostic information. Herein, we review the recent findings on cell-free DNA alterations in patients with prostate cancer and discuss its diagnostic and prognostic potential.

Keywords: Prostate cancer, DNA fragmentation, cell-free DNA, DNA methylation, allelic imbalance.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 17 April, 2014
Page: [258 - 264]
Pages: 7
DOI: 10.2174/157339470904140418094329
Price: $65

Article Metrics

PDF: 11